---
figid: PMC3666312__nihms-463012-f0001
figlink: /pmc/articles/PMC3666312/figure/F1/
number: F1
caption: 'Signal 1 results from MHC–antigen recognition through the T-cell receptor–CD3
  complex, a process blocked by anti-CD3 mAbs and indirectly by rituximab. Signal
  2 results in costimulation, a process that can be blocked by belatacept. Costimulation
  activates downstream signaling pathways, resulting in calcineurin activation, a
  stage that can be inhibited by tacrolimus and cyclosporine A. Activated calcineurin
  dephosphorylates NF-AT, allowing IL-2 transcription to initiate signal 3. IL-2 receptor
  stimulation, a step that can be blocked by basiliximab, activates the mTOR signaling
  cascade, which can be inhibited by sirolimus. This pathway induces the T cell to
  enter the cell cycle and proliferate, which in turn can be blocked by methotrexate,
  mycophenolate and azathioprine. rATG exerts polyclonal effects while alemtuzumab
  binds to CD52, both resulting in immunodepletion. mAb: Monoclonal antibody; NF-AT:
  Nuclear factor of activated T cell; rATG: Rabbit antithymocyte globulin.'
pmcid: PMC3666312
papertitle: Current landscape for T-cell targeting in autoimmunity and transplantation.
reftext: Daniel R Getts, et al. Immunotherapy. ;3(7):853-870.
pmc_ranked_result_index: '36289'
pathway_score: 0.9740931
filename: nihms-463012-f0001.jpg
figtitle: Current landscape for T-cell targeting in autoimmunity and transplantation
year: ''
organisms: Homo sapiens
ndex: a8b224c6-dec2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3666312__nihms-463012-f0001.html
  '@type': Dataset
  description: 'Signal 1 results from MHC–antigen recognition through the T-cell receptor–CD3
    complex, a process blocked by anti-CD3 mAbs and indirectly by rituximab. Signal
    2 results in costimulation, a process that can be blocked by belatacept. Costimulation
    activates downstream signaling pathways, resulting in calcineurin activation,
    a stage that can be inhibited by tacrolimus and cyclosporine A. Activated calcineurin
    dephosphorylates NF-AT, allowing IL-2 transcription to initiate signal 3. IL-2
    receptor stimulation, a step that can be blocked by basiliximab, activates the
    mTOR signaling cascade, which can be inhibited by sirolimus. This pathway induces
    the T cell to enter the cell cycle and proliferate, which in turn can be blocked
    by methotrexate, mycophenolate and azathioprine. rATG exerts polyclonal effects
    while alemtuzumab binds to CD52, both resulting in immunodepletion. mAb: Monoclonal
    antibody; NF-AT: Nuclear factor of activated T cell; rATG: Rabbit antithymocyte
    globulin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPP3CA
  - APC
  - PPP3CC
  - CDK11A
  - CDK10
  - CDK15
  - CDK3
  - CDK4
  - CDK17
  - CDK5
  - NFATC3
  - NFATC4
  - CDKL5
  - CDK19
  - CDK13
  - NFAT5
  - PPP3R1
  - CDK12
  - CDK14
  - CDK16
  - CD52
  - CDK18
  - PPP3CB
  - MTOR
  - CDK2
  - CDK6
  - CDK9
  - NFATC2
  - CDK8
  - CDK20
  - CDKL3
  - IL2
  - NFATC1
  - CDKL1
  - CDKL4
  - CDK1
  - PPP3R2
  - CDK7
  - CDKL2
  - CDK11B
  - CD28
  - Azathioprine
  - Methotrexate
  - Tacrolimus
  - Cyclosporine
  - Sirolimus
genes:
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: CD52
  symbol: CD52
  source: hgnc_symbol
  hgnc_symbol: CD52
  entrez: '1043'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: NF-AT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: Cyclin/CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
chemicals:
- word: Azathioprine
  source: MESH
  identifier: D001379
- word: Methotrexate
  source: MESH
  identifier: D008727
- word: Tacrolimus
  source: MESH
  identifier: D016559
- word: Cyclosporine
  source: MESH
  identifier: D016572
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC3666312__F1
redirect_from: /figures/PMC3666312__F1
figtype: Figure
---
